Overview

Mechanical Opening Device Implantation Following Intravenous r-tPA for Recanalization in Acute Ischemic Stroke

Status:
Unknown status
Trial end date:
2017-04-01
Target enrollment:
Participant gender:
Summary
This study is to test a hypothesis that temporary implantation of JRecanTM blood flow recanalisation device within 6.5 hours of symptom onset of acute ischemic stroke due to a major intracranial artery occlusion following IV r-tPA can provide a greater rate of early successful recanalisation than treatment of IV r-tPA alone.
Phase:
Phase 2
Details
Lead Sponsor:
The Second Artillery General Hospital
Collaborator:
Hunan Rui Kang Tong technology development co., LTD
Treatments:
Plasminogen
Tissue Plasminogen Activator